Quantbot Technologies LP purchased a new position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 5,604 shares of the technology company's stock, valued at approximately $718,000.
Several other institutional investors have also modified their holdings of PLXS. American Century Companies Inc. lifted its stake in Plexus by 24.7% in the 1st quarter. American Century Companies Inc. now owns 678,222 shares of the technology company's stock valued at $86,901,000 after buying an additional 134,205 shares in the last quarter. Nuveen Asset Management LLC increased its holdings in shares of Plexus by 6.6% during the 4th quarter. Nuveen Asset Management LLC now owns 351,557 shares of the technology company's stock worth $55,012,000 after buying an additional 21,911 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Plexus by 10.0% during the 4th quarter. Northern Trust Corp now owns 332,100 shares of the technology company's stock worth $51,967,000 after buying an additional 30,163 shares during the last quarter. Invesco Ltd. increased its holdings in Plexus by 66.1% in the 1st quarter. Invesco Ltd. now owns 211,741 shares of the technology company's stock valued at $27,130,000 after purchasing an additional 84,249 shares in the last quarter. Finally, Victory Capital Management Inc. increased its holdings in Plexus by 8.3% in the 1st quarter. Victory Capital Management Inc. now owns 185,200 shares of the technology company's stock valued at $23,730,000 after purchasing an additional 14,267 shares in the last quarter. Hedge funds and other institutional investors own 94.45% of the company's stock.
Plexus Stock Down 2.0%
Shares of PLXS stock traded down $2.80 during trading hours on Friday, hitting $136.82. 35,418 shares of the company were exchanged, compared to its average volume of 177,630. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58. Plexus Corp. has a one year low of $103.43 and a one year high of $172.89. The business's 50-day simple moving average is $133.01 and its two-hundred day simple moving average is $130.05. The stock has a market capitalization of $3.69 billion, a price-to-earnings ratio of 23.35 and a beta of 0.80.
Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.02 billion. During the same quarter last year, the company posted $1.45 earnings per share. The company's quarterly revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Sell-side analysts predict that Plexus Corp. will post 5.9 EPS for the current fiscal year.
Insider Activity at Plexus
In other news, COO Oliver K. Mihm sold 2,102 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $130.43, for a total transaction of $274,163.86. Following the transaction, the chief operating officer owned 21,155 shares of the company's stock, valued at approximately $2,759,246.65. This trade represents a 9.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Patrick John Jermain sold 2,178 shares of the firm's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $130.42, for a total transaction of $284,054.76. Following the completion of the transaction, the chief financial officer directly owned 23,459 shares in the company, valued at $3,059,522.78. This represents a 8.50% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 8,856 shares of company stock worth $1,158,610. 1.76% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Several analysts have recently weighed in on the company. Needham & Company LLC lowered their target price on Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research note on Thursday, July 24th. Benchmark restated a "buy" rating and set a $160.00 target price on shares of Plexus in a research note on Wednesday, June 4th. Sidoti upgraded Plexus from a "neutral" rating to a "buy" rating and raised their target price for the company from $135.00 to $150.00 in a research note on Friday, July 25th. Stifel Nicolaus set a $140.00 target price on Plexus in a research note on Thursday, July 24th. Finally, Wall Street Zen downgraded Plexus from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 16th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Plexus currently has a consensus rating of "Moderate Buy" and a consensus target price of $152.00.
Check Out Our Latest Analysis on PLXS
Plexus Company Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.